The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
[11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 3×
“Previous studies also show variable results with several analysis methods using different adjustments to obtain the reference region [6–9].”
MethodResult
Research works printed but not linked: 10
- Teismann, 2003, Pathogenic role of glial cells in Parkinson's disease, Mov Disord, 18, 121, 10.1002/mds.10332 · DOI · Paper page
- Chen, 2003, Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease, Arch Neurol, 60, 1059, 10.1001/archneur.60.8.1059 · DOI · Paper page
- Sanchez-Pernaute, 2004, Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease, J Neuroinflammation, 1, 6, 10.1186/1742-2094-1-6 · DOI
- Teismann, 2003, Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration, Proc Natl Acad Sci USA, 100, 5473, 10.1073/pnas.0837397100 · DOI · Paper page
- Ouchi, 2005, Microglial activation and dopamine terminal loss in early Parkinson's disease, Ann Neurol, 57, 168, 10.1002/ana.20338 · DOI · Paper page
- Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321 · DOI · Paper page
- Schuitemaker, 2007, Evaluation of methods for generating parametric (R-[11C]PK11195 binding images, J Cereb Blood Flow Metab, 27, 1603, 10.1038/sj.jcbfm.9600459 · DOI
- Colville-Nash, 2001, Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation, BioDrugs, 15, 1, 10.2165/00063030-200115010-00001 · DOI
- Boutin, 2007, 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation, J Nucl Med, 48, 573, 10.2967/jnumed.106.036764 · DOI · Paper page
- Imaizumi, 2008, Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors, Neuroimage, 39, 1289, 10.1016/j.neuroimage.2007.09.063 · DOI
Cited by
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
Insulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
Metadata
- Authors
- Bartels, A. L., Willemsen, A. T. M., Doorduin, J., de Vries, E. F. J., Dierckx, R. A., & Leenders, K. L.
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 16
- Issue
- 1
- Pages
- 57-59
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2095718867
- Cited by
- 181
- References
- 2
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? https://app.cochat.ai/papers/10.1016/j.parkreldis.2009.05.005
- The paper
- Bartels, A. L., Willemsen, A. T. M., Doorduin, J., de Vries, E. F. J., Dierckx, R. A., & Leenders, K. L. (2010). [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2009.05.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.